1. Home
  2. IPHA vs HNVR Comparison

IPHA vs HNVR Comparison

Compare IPHA & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • HNVR
  • Stock Information
  • Founded
  • IPHA 1999
  • HNVR 2008
  • Country
  • IPHA France
  • HNVR United States
  • Employees
  • IPHA N/A
  • HNVR N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • HNVR Commercial Banks
  • Sector
  • IPHA Health Care
  • HNVR Finance
  • Exchange
  • IPHA Nasdaq
  • HNVR Nasdaq
  • Market Cap
  • IPHA 160.1M
  • HNVR 155.2M
  • IPO Year
  • IPHA 2019
  • HNVR 2022
  • Fundamental
  • Price
  • IPHA $1.74
  • HNVR $22.80
  • Analyst Decision
  • IPHA Strong Buy
  • HNVR Buy
  • Analyst Count
  • IPHA 1
  • HNVR 1
  • Target Price
  • IPHA $11.00
  • HNVR $22.00
  • AVG Volume (30 Days)
  • IPHA 11.2K
  • HNVR 42.0K
  • Earning Date
  • IPHA 09-11-2025
  • HNVR 07-23-2025
  • Dividend Yield
  • IPHA N/A
  • HNVR 1.74%
  • EPS Growth
  • IPHA N/A
  • HNVR N/A
  • EPS
  • IPHA N/A
  • HNVR 1.31
  • Revenue
  • IPHA $20,831,349.00
  • HNVR $65,041,000.00
  • Revenue This Year
  • IPHA $209.83
  • HNVR N/A
  • Revenue Next Year
  • IPHA $83.15
  • HNVR $13.69
  • P/E Ratio
  • IPHA N/A
  • HNVR $17.56
  • Revenue Growth
  • IPHA N/A
  • HNVR 5.06
  • 52 Week Low
  • IPHA $1.29
  • HNVR $16.06
  • 52 Week High
  • IPHA $3.51
  • HNVR $27.14
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 42.70
  • HNVR 56.53
  • Support Level
  • IPHA $1.71
  • HNVR $22.80
  • Resistance Level
  • IPHA $1.90
  • HNVR $23.31
  • Average True Range (ATR)
  • IPHA 0.08
  • HNVR 0.70
  • MACD
  • IPHA 0.00
  • HNVR 0.13
  • Stochastic Oscillator
  • IPHA 47.62
  • HNVR 65.44

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.

Share on Social Networks: